The pitfalls of femoropopliteal stenting trials

Journal of Endovascular Therapy

Volumn 19, Issue 5, 2012, Pages 596-598

  Mwipatayi, Bibombe P ^a,b   Leong, Benjamin D K ^a   Hockley, Joe ^a   Vijayan, Vikram ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID PLUS CLOPIDOGREL;

ANTICOAGULANT THERAPY; CLINICAL TRIAL (TOPIC); DOPPLER ECHOGRAPHY; DRUG ELUTING STENT; FEMOROPOPLITEAL STENTING; GRAFT FAILURE; GRAFT PATENCY; HUMAN; INCIDENCE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RESTENOSIS; REVIEW; STENT; SUPERFICIAL FEMORAL ARTERY;

ALLOYS; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; FEMALE; FEMORAL ARTERY; HUMANS; MALE; POPLITEAL ARTERY; STENTS;

EID: 84868354430     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/JEVT-12-3898C.1     Document Type: Review

References (18)

1. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction. description of a new technic and a preliminary report of its application. Circulation. 1964;30:654-670.
2. Gruntzig A, Hopff H. [Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique) (author's transl)]. Dtsch Med Wochenschr. 1974;99:2502-2511.
3. Anderson PL, Gelijns A, Moskowitz A, et al. Understanding trends in inpatient surgical volume: Vascular interventions, 1980-2000. J Vasc Surg. 2004;39:1200-1208.
4. Goodney PP, Beck AW, Nagle J, et al. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50:54-60.
5. Rowe VL, Lee W, Weaver FA, et al, Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg. 2009;49: 910-917.
6. Acin F, de Haro J, Bleda S, et al. Primary nitinol stenting in femoropopliteal occlusive disease: A meta-analysis of randomized controlled trials. J Endovasc Ther. 2012;19:585-595.
7. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67.
8. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115: 2745-279.
9. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315.
10. Duda SH, Pusich B, Richter G, et al. Sirolimuseluting stents for the treatment of obstructive superficial femoral artery disease: Six-month results. Circulation. 2002;106:1505-1509.
11. Nakazawa G, Finn AV, Vorpahl M, et al. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009;54:1924-1931.
12. Ling AJ, Mwipatayi P, Gandhi T, et al. Stenting for carotid artery stenosis: Fractures, proposed etiology and the need for surveillance. J Vasc Surg. 2008;47:1220-1226.
13. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261-269.
14. Laird JR, Katzen BT, Scheinert D, et al.; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
15. Rosenschein U, Topol EJ. Uncoupling clinical outcomes and coronary angiography: A review and perspective of recent trials in coronary artery disease. Am Heart J. 1996;132:910-920.
16. Cacoub PP, Bhatt DL, Steg PG, et al. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J. 2009;30:192-201.
17. Dorffler-Melly J, Koopman MM, Prins MH, et al. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database Syst Rev. 2005(1):CD002071.
18. Tepe G, Bantleon R, Brechtel K, et al. Management of peripheral arterial interventions with mono or dual antiplatelet therapy-the MIRROR study: A randomised and double-blinded clinical trial. Eur Radiol. 2012 May 10. [Epub ahead of print]